G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 27.75 SEK 3.74% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genovis AB
Other Equity Peer Comparison

Comparables:
ALIF B
BICO
BIOT
MCAP
M
MAGLE

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Other Equity
kr207.6m
CAGR 3-Years
32%
CAGR 5-Years
48%
CAGR 10-Years
22%
AddLife AB
STO:ALIF B
Other Equity
kr5B
CAGR 3-Years
N/A
CAGR 5-Years
40%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Other Equity
kr3.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Other Equity
kr30m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Other Equity
kr1.2B
CAGR 3-Years
23%
CAGR 5-Years
30%
CAGR 10-Years
17%
M
Magle Chemoswed Holding AB
STO:MAGLE
Other Equity
kr40.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Genovis AB's Other Equity?
Other Equity
207.6m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Other Equity amounts to 207.6m SEK.

What is Genovis AB's Other Equity growth rate?
Other Equity CAGR 10Y
22%

Over the last year, the Other Equity growth was 11%. The average annual Other Equity growth rates for Genovis AB have been 32% over the past three years , 48% over the past five years , and 22% over the past ten years .

Back to Top